Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma

Bedke, Jens; Rini, Brian, I; Plimack, Elizabeth R.; Stus, Viktor; Gafanov, Rustem; Waddell, Tom; Nosov, Dimitry; Pouliot, Frederic; Soulieres, Denis; Melichar, Bohuslav; Vynnychenko, Ihor; Azevedo, Sergio J.; Borchiellini, Delphine; McDermott, Raymond S.; Tamada, Satoshi; Nguyen, Allison Martin; Wan, Shuyan; Perini, Rodolfo F.; Molife, L. Rhoda; Atkins, Michael B.; Powles, Thomas

Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma

Autor(en):

Bedke, Jens; Rini, Brian, I; Plimack, Elizabeth R.; Stus, Viktor; Gafanov, Rustem; Waddell, Tom; Nosov, Dimitry; Pouliot, Frederic; Soulieres, Denis; Melichar, Bohuslav; Vynnychenko, Ihor; Azevedo, Sergio J.; Borchiellini, Delphine; McDermott, Raymond S.; Tamada, Satoshi; Nguyen, Allison Martin; Wan, Shuyan; Perini, Rodolfo F.; Molife, L. Rhoda; Atkins, Michael B.; Powles, Thomas

Tübinger Autor(en):

Bedke, Jens

Erschienen in:

European Urology (2022), Bd. 82, H. 4, S. 427-439

Verlagsangabe:

Amsterdam : Elsevier

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.eururo.2022.06.009

ISSN:

0302-2838